866-997-4948(US-Canada Toll Free)

Global Cell Therapy Market 2017-2021

Published By :

Technavio

Published Date : Sep 2017

Category :

In Vitro Diagnostics

No. of Pages : 118 Pages

About Cell Therapy

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.

Technavios analysts forecast the global cell therapy market to grow at a CAGR of 23.27% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global cell therapy market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Dendreon
Mesoblast
Vericel

Other prominent vendors
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
CellPraxis
CellSeed
Cell Therapy
Celyad
CESCA THERAPEUTICS
CRC for Cell Therapy Manufacturing
CryoLife
Cynata Therapeutics
Cytori Therapeutics
DiscGenics
Fate Therapeutics
Fibrocell Science
Forticell Bioscience
Fortress Biotech
Gamida Cell
GlaxoSmithKline
Healthpoint
Histogen
Histogenics
Holostem Terapie Avanzate
Humacyte
Immunocellular Therapeutics
Integra Life Sciences
Intercytex
iSTO Technologies
Janssen Pharma
Juno Therapeutics
Juventas Therapeutics
Kensey Nash
Kite Pharma
Kiadis Pharma
LifeNet Health
Living Cell Technologies
Lonza
MaxCyte
MEDIPOST
Nanofiber Solutions
Nanotope
Neuralstem
Newlink Genetics
Northwest Biotherapeutics
NovaRx
Ocata Therapeutics
Opexa Therapeutics
Orbsen Therapeutics
Pfizer
Pharmicell
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
Regenerexx
Regeneus
Regenerys
Regience
Regrow
RepliCel
ReproCELL
ReNeuron

RenovaCare
RESSTORE
RhinoCyte
Rohto Pharmaceutical
SanBio
Sangamo BioSciences
Shanghai Sunway Biotech
Shire Regenerative Medicine
StemCells
STEMPEUTICS RESEARCH
Synergistic Technologies
t2cure
Takara Bio
tella
Tengion
TissueGene
Tessa Therapeutics
Txcell
VentriNova
ViaCyte
VistaGen Therapeutics
SDRMI and Xcelthera

Market driver
Increase in prevalence of chronic diseases
For a full, detailed list, view our report

Market challenge
High cost of clinical trials and cell therapy doses
For a full, detailed list, view our report

Market trend
Proliferation of strategic alliances and royalty payments
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Overview
Government funding and support
PART 05: Market landscape
Overview
Market size and forecast
PART 06: Pipeline portfolio
Overview
Regulatory framework for cell therapy products
Pipeline analysis
Five forces analysis
PART 07: Segmentation by application
Overview
Dermatology
Musculoskeletal
Ocular
Cardiovascular
PART 08: Segmentation by end-user
Hospitals and clinics
ASCs
Regenerative medicine centers
PART 09: Segmentation by geography
Overview
Americas
EMEA
APAC
PART 10: Decision framework
PART 11: Drivers and challenges
Market drivers
Market challenges
PART 12: Market trends
Focus on business strategies
Proliferation of strategic alliances and royalty payments
Geographic expansion of gene therapy
PART 13: Vendor landscape
Competitive landscape
PART 14: Key vendor analysis
Dendreon
Mesoblast
Vericel
Other prominent vendors
PART 15: Appendix
List of abbreviations

List of Exhibits
Exhibit 01: Types of stem cells used in cell therapy products: Overview
Exhibit 02: Collaborative funding for cell therapy-based research in US
Exhibit 03: Ethical challenges associated with stem cell research
Exhibit 04: Stem cell research policies in countries in Americas
Exhibit 05: Stem cell research policies in countries in EMEA
Exhibit 06: Stem cell research policies in countries in APAC
Exhibit 07: Global cell therapy market 2016-2021 ($ billions)
Exhibit 08: Global cell therapy market: Overview
Exhibit 09: Cell therapy pipeline for CVDs
Exhibit 10: Cell therapy pipelines for CNS, orthopedic, and ocular disorders
Exhibit 11: Cell therapy pipeline for dermatology and diabetes
Exhibit 12: Cell therapy pipeline for oncology
Exhibit 13: Five forces analysis
Exhibit 14: Global stem cell therapy market: Segmentation by application 2016 (% share)
Exhibit 15: Cell therapy for dermatology: Overview
Exhibit 16: Cell therapy for burns and diabetic wound treatment: Opportunity analysis
Exhibit 17: Cell therapy products for dermatology pipeline
Exhibit 18: Cell therapy for musculoskeletal: Overview
Exhibit 19: Cell therapy for occupational and sports-related injuries: Overview
Exhibit 20: Cell therapy for musculoskeletal pipeline
Exhibit 21: Cell therapy for ocular: Overview
Exhibit 22: Cell therapy for ocular pipeline
Exhibit 23: Cell therapy for cardiovascular: Overview
Exhibit 24: Cell therapy for cardiovascular: Overview
Exhibit 25: Global cell therapy market: Overview of segmentation by end-user
Exhibit 26: Funding and partnership for cell therapy product development
Exhibit 27: Hospital collaborations for cell therapy
Exhibit 28: Global cell therapy market: Segmentation by geography 2016 and 2021 ($ billions)
Exhibit 29: Cell therapy market in Americas: Overview
Exhibit 30: Cell therapy market in Americas 2016-2021 ($ billions)
Exhibit 31: Cell therapy market in Americas: Overview by country
Exhibit 32: SBIR and STTR programs
Exhibit 33: Cell therapy market in US: Overview
Exhibit 34: Cell therapy market in EMEA: Overview
Exhibit 35: Cell therapy market in EMEA 2016-2021 ($ billions)
Exhibit 36: Cell therapy market in EMEA: Overview by country
Exhibit 37: Cell therapy market in UK
Exhibit 38: Cell therapy market in APAC 2016-2021 ($ billions)
Exhibit 39: Cell therapy market in APAC: Overview by country
Exhibit 40: Cell therapy market in Japan: Overview
Exhibit 41: Chronic diseases in US and Europe
Exhibit 42: Fall and hip fracture in US 2016
Exhibit 43: Number of road injuries in UK 2015
Exhibit 44: Regulatory challenges associated with regenerative medicine
Exhibit 45: Key business strategies adopted by companies
Exhibit 46: Major strategic alliances
Exhibit 47: Competitive structure analysis
Exhibit 48: Competitive landscape
Exhibit 49: Strategies for companies
Exhibit 50: Key recommendations for new entrants
Exhibit 51: Dendreon: Key highlights
Exhibit 52: Dendreon: Strength assessment
Exhibit 53: Dendreon: Strategy assessment
Exhibit 54: Dendreon: Opportunity assessment
Exhibit 55: Mesoblast: Key highlights
Exhibit 56: Mesoblast: Strength assessment
Exhibit 57: Mesoblast: Strategy assessment
Exhibit 58: Mesoblast: Opportunity assessment
Exhibit 59: Vericel: Key highlights
Exhibit 60: Vericel: Strength assessment
Exhibit 61: Vericel: Strategy assessment
Exhibit 62: Vericel: Opportunity assessment

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *